Tag: Dr. Cindy Orser

Las Vegas Cannabis Testing News and More

Inherent Residual Solvents In Your Cannabis

Inherent Residual Solvents In Your Cannabis

Individual assumptions about organic solvents probably vary quite a bit, but normally the term “organic solvents” conjure up putrid visions of poisonous, flammable and toxic vapors, but not all organic solvents fall into that fearful category.  We can’t always see or smell them, but they are volatile, and typically measured using a GC/MS with headspace […]

Read More

The Role of Science in Society & Cannabis

The Role of Science in Society & Cannabis

Who doesn’t love science?  From dinosaurs to galaxies far, far away; from the interdependence of life with death, the scourge of disease, the gift and curse of radioactivity.  At some level, everyone appreciates and enjoys learning about the world around them on this rock we call Earth, whirling at 17,672 mph through the seemingly infinite […]

Read More

The National Academies Has Spoken

The National Academies Has Spoken

At this crucial time for cannabis policy and national standing, a subcommittee of The National Academies of Sciences, Engineering & Medicine has released a pre-publication entitled, “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.”  The National Academy of Sciences, a revered institution, was established by President Lincoln […]

Read More

The Case for Mandatory Genotyping

The Case for Mandatory Genotyping

As the cannabis industry continues to grow across the United States at a rapid pace, the competition amongst growers and producers is also heating up. This competition is reflected in dropping prices at both the wholesale and retail level. There are few options for growers to regain market share in the flooded retail market space. […]

Read More

Curtailment In Oregon’s Cannabis Market

Curtailment In Oregon’s Cannabis Market

By Cindy Orser, PhD, Chief Science Officer of Digipath Labs The news of Oregon’s cannabis market coming to its knees because of strict testing requirements casts a long shadow on those states faced with rolling out newly voter-approved MMJ or retail cannabis programs.  One can easily conclude from the rising national awareness of the prevalence of tainted cannabis […]

Read More

Cannabis Use Disorder

1
Cannabis Use Disorder

By Cindy Orser, PhD, Chief Science Officer of Digipath Labs ‘Cannabis Use Disorder,’ or CUD for short is described as a new mental health condition categorized in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), the diagnostic bible of psychiatrists.  The DSM publication is used by clinicians, researchers, drug regulatory agencies, health insurance […]

Read More

When Retail Marijuana Competes with Medical Marijuana

When Retail Marijuana Competes with Medical Marijuana

By Cindy Orser, PhD, Chief Science Officer of Digipath Labs  On November 8th the citizens of five states, Nevada, California, Maine, Arizona and Massachusetts, all with existing medical marijuana (MMJ) programs will be voting on the legalization of recreational marijuana. These states could be joining Alaska, Washington, Oregon, Colorado and the District of Columbia with dueling marijuana programs […]

Read More

Toward A Sampling Plan For Cannabis

Toward A Sampling Plan For Cannabis

By Cindy Orser | Chief Science Officer There are two major considerations in determining a sampling strategy for a cannabis harvest or production batch: 1) the number of samples to be taken from a defined unit test batch, harvest or production; and, 2) the amount (mass) of each of those samples and whether they are […]

Read More

The Future of Cannabis Micropropagation

1
The Future of Cannabis Micropropagation

By Dr. Cindy Orser | Chief Science Officer of Digipath Labs The in vitro sterile micropropagation of plants in tissue culture provides an option for preserving plant germplasm for the future; however, the likelihood of somaclonal variation, where the desired genotype is not strictly maintained, has been a drawback for the past decades. Somaclonal variation […]

Read More

Rethinking Microbial Screening

Rethinking Microbial Screening

In the current method of microbial screening, the current microbial bioburden limits for total aerobic bacteria and total yeast and mold on cannabis in Nevada are too restrictive for those growers whose use of beneficial microbes is in compliance with the Nevada Department of Agriculture’s current acceptable list of pesticides. Therefore, the use of certain […]

Read More